184 related articles for article (PubMed ID: 27758762)
1. Biomarkers of neuroendocrine tumors.
d'Herbomez M; Coppin L; Bauters C; Rouaix-Emery N; Carnaille B; Do Cao C
Ann Biol Clin (Paris); 2016 Dec; 74(6):669-679. PubMed ID: 27758762
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic endocrine tumors: diagnostic pitfalls.
Ectors N
Hepatogastroenterology; 1999; 46(26):679-90. PubMed ID: 10370596
[No Abstract] [Full Text] [Related]
3. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
4. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
5. [Pancreatic endocrine tumors - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)].
Kos-Kudła B; Bolanowski M; Hubalewska-Dydejczyk A; Krzakowski M; Marek B; Nasierowska-Guttmejer A; Lampe P; Sworczak K;
Endokrynol Pol; 2008; 59(1):68-86. PubMed ID: 18335402
[TBL] [Abstract][Full Text] [Related]
6. [Neuroendocrine tumors of the gastrointestinal-pancreatic system. Classification and diagnosis].
Tiling N; Ricke J; Wiedenmann B
Internist (Berl); 2002 Feb; 43(2):210-8. PubMed ID: 11963758
[No Abstract] [Full Text] [Related]
7. Insulinoma: a rare neuroendocrine pancreatic tumor.
Stamatakos M; Safioleas C; Tsaknaki S; Safioleas P; Iannescu R; Safioleas M
Chirurgia (Bucur); 2009; 104(6):669-73. PubMed ID: 20187464
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
Szczeblowska D
Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors.
Imamura M; Nakamoto Y; Uose S; Komoto I; Awane M; Taki Y
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):602-9. PubMed ID: 25624017
[TBL] [Abstract][Full Text] [Related]
10. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
Goldin SB; Aston J; Wahi MM
Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
[TBL] [Abstract][Full Text] [Related]
11. False positives and false negatives in neuroendocrine tumors diagnosis: clinical reports.
Ducceschi M; Pusceddu S; Platania M
Tumori; 2010; 96(5):827-32. PubMed ID: 21302640
[TBL] [Abstract][Full Text] [Related]
12. Role of biomarker tests for diagnosis of neuroendocrine tumours.
Hofland J; Zandee WT; de Herder WW
Nat Rev Endocrinol; 2018 Nov; 14(11):656-669. PubMed ID: 30158549
[TBL] [Abstract][Full Text] [Related]
13. Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors.
Anderson CW; Bennett JJ
Surg Oncol Clin N Am; 2016 Apr; 25(2):363-74. PubMed ID: 27013370
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry of neuroendocrine tumours.
de Herder WW
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract][Full Text] [Related]
16. [Neuroendocrine tumors of the digestive system].
Prónai L; Rácz K; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
[TBL] [Abstract][Full Text] [Related]
17. GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers.
Verbeek WH; Korse CM; Tesselaar ME
Eur J Endocrinol; 2016 Jan; 174(1):R1-7. PubMed ID: 26162406
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
Singh S; Law C
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
